JP2019510509A5 - - Google Patents

Download PDF

Info

Publication number
JP2019510509A5
JP2019510509A5 JP2018561784A JP2018561784A JP2019510509A5 JP 2019510509 A5 JP2019510509 A5 JP 2019510509A5 JP 2018561784 A JP2018561784 A JP 2018561784A JP 2018561784 A JP2018561784 A JP 2018561784A JP 2019510509 A5 JP2019510509 A5 JP 2019510509A5
Authority
JP
Japan
Prior art keywords
cell
cells
positive
negative
corneal endothelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018561784A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019510509A (ja
JP7008337B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2017/005386 external-priority patent/WO2017141926A1/en
Publication of JP2019510509A publication Critical patent/JP2019510509A/ja
Priority to JP2020022800A priority Critical patent/JP7453669B2/ja
Priority to JP2020022799A priority patent/JP6954682B2/ja
Publication of JP2019510509A5 publication Critical patent/JP2019510509A5/ja
Application granted granted Critical
Publication of JP7008337B2 publication Critical patent/JP7008337B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018561784A 2016-02-15 2017-02-14 ヒト機能性角膜内皮細胞およびその応用 Active JP7008337B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2020022800A JP7453669B2 (ja) 2016-02-15 2020-02-13 ヒト機能性角膜内皮細胞およびその応用
JP2020022799A JP6954682B2 (ja) 2016-02-15 2020-02-13 ヒト機能性角膜内皮細胞およびその応用

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
JP2016026423 2016-02-15
JP2016026426 2016-02-15
JP2016026423 2016-02-15
JP2016026424 2016-02-15
JP2016026425 2016-02-15
JP2016026424 2016-02-15
JP2016026425 2016-02-15
JP2016026426 2016-02-15
JP2016077450 2016-04-07
JP2016077450 2016-04-07
PCT/JP2017/005386 WO2017141926A1 (en) 2016-02-15 2017-02-14 Human functional corneal endothelial cell and application thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2020022800A Division JP7453669B2 (ja) 2016-02-15 2020-02-13 ヒト機能性角膜内皮細胞およびその応用
JP2020022799A Division JP6954682B2 (ja) 2016-02-15 2020-02-13 ヒト機能性角膜内皮細胞およびその応用

Publications (3)

Publication Number Publication Date
JP2019510509A JP2019510509A (ja) 2019-04-18
JP2019510509A5 true JP2019510509A5 (https=) 2020-04-02
JP7008337B2 JP7008337B2 (ja) 2022-02-10

Family

ID=58261691

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2018561784A Active JP7008337B2 (ja) 2016-02-15 2017-02-14 ヒト機能性角膜内皮細胞およびその応用
JP2020022799A Active JP6954682B2 (ja) 2016-02-15 2020-02-13 ヒト機能性角膜内皮細胞およびその応用
JP2020022800A Active JP7453669B2 (ja) 2016-02-15 2020-02-13 ヒト機能性角膜内皮細胞およびその応用
JP2023205812A Pending JP2024019306A (ja) 2016-02-15 2023-12-06 ヒト機能性角膜内皮細胞およびその応用
JP2025182944A Pending JP2026021433A (ja) 2016-02-15 2025-10-29 ヒト機能性角膜内皮細胞およびその応用
JP2025182943A Pending JP2026012325A (ja) 2016-02-15 2025-10-29 ヒト機能性角膜内皮細胞およびその応用

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2020022799A Active JP6954682B2 (ja) 2016-02-15 2020-02-13 ヒト機能性角膜内皮細胞およびその応用
JP2020022800A Active JP7453669B2 (ja) 2016-02-15 2020-02-13 ヒト機能性角膜内皮細胞およびその応用
JP2023205812A Pending JP2024019306A (ja) 2016-02-15 2023-12-06 ヒト機能性角膜内皮細胞およびその応用
JP2025182944A Pending JP2026021433A (ja) 2016-02-15 2025-10-29 ヒト機能性角膜内皮細胞およびその応用
JP2025182943A Pending JP2026012325A (ja) 2016-02-15 2025-10-29 ヒト機能性角膜内皮細胞およびその応用

Country Status (6)

Country Link
US (3) US20190083543A1 (https=)
EP (2) EP3416658B1 (https=)
JP (6) JP7008337B2 (https=)
ES (1) ES2947826T3 (https=)
PL (1) PL3416658T3 (https=)
WO (1) WO2017141926A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2858173C (en) 2011-12-06 2023-09-26 Advanced Cell Technology, Inc. Method of directed differentiation producing corneal endothelial cells, compositions thereof, and uses thereof
EP3416658B1 (en) 2016-02-15 2023-03-22 Kyoto Prefectural Public University Corporation Human functional corneal endothelial cell and application thereof
CN107629999A (zh) * 2017-10-18 2018-01-26 清华大学深圳研究生院 一种增加间充质干细胞外泌体产生及分泌的方法
US12350294B2 (en) 2018-01-16 2025-07-08 Keio University Medium comprising serum replacement, IGF1, STAT3 activator and adrenal gland hormone without BFGF or rock inhibitor for producing corneal endothelial substitute cells from iPS cells and a method thereof
EP3893904A4 (en) * 2018-12-12 2022-08-17 The Johns Hopkins University GENERATION AND CRYOPRESERVATION OF CLINICAL-QUALITY CORNEAL EDDELLIAL CELLS FROM PLURIPOTENTIC STEM CELLS
KR102446567B1 (ko) * 2019-04-17 2022-09-26 연세대학교 산학협력단 각막 내피 세포의 기능 부전 진단용 바이오마커
JP2020200296A (ja) * 2019-06-13 2020-12-17 久貴 藤本 角膜内皮障害の予防及び/又は治療のための薬剤
US12230397B2 (en) * 2019-08-21 2025-02-18 Case Western Reserve University Assessment of endothelial cells and corneas at risk from ophthalmological images
WO2021172554A1 (ja) 2020-02-27 2021-09-02 京都府公立大学法人 ヒト機能性角膜内皮細胞およびその応用
WO2022025239A1 (ja) * 2020-07-31 2022-02-03 学校法人同志社 角膜内皮細胞注入療法の治療効果増強法
AU2021366805B2 (en) * 2020-10-22 2025-04-24 Kyoto Prefectural Public University Corporation A storage method of human corneal endothelial cells and/or human corneal endothelial precursor cells
CN112538458B (zh) * 2020-11-26 2025-10-31 北京孟眸生物科技有限公司 用于重编程细胞的方法
US20240350552A1 (en) 2021-07-07 2024-10-24 Cellusion Inc. Therapeutic composition containing corneal endothelium replacement cells
WO2023282338A1 (ja) 2021-07-07 2023-01-12 株式会社セルージョン 細胞播種剤及び細胞移植用基材
CN114507635B (zh) * 2022-01-24 2024-03-22 上海纽仁生物医药科技有限公司 一种动物神经系统内皮细胞单细胞的分离方法
WO2023190941A1 (ja) * 2022-03-31 2023-10-05 学校法人同志社 培養由来成分を含まない角膜内皮細胞製剤及びその製造法
WO2023230171A2 (en) * 2022-05-24 2023-11-30 University Of Pittsburgh - Of Thecommonwealth System Of Highereducation Compositions and methods of treating corneal scarring
EP4655392A2 (en) * 2023-01-27 2025-12-03 Universiteit Maastricht Methods for selecting cultured corneal endothelial cells
WO2024182683A1 (en) * 2023-03-01 2024-09-06 The Regents Of The University Of California Rapid, accurate, and reproducible screening of endothelial cell morphology in diseased and healthy corneas
KR20250024502A (ko) * 2023-08-11 2025-02-18 재단법인 아산사회복지재단 분화 유도된 각막 내피 세포를 포함하는 각막 질환 예방 또는 치료용 약학적 조성물

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678783B1 (en) 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
JP3421217B2 (ja) 1995-11-20 2003-06-30 麒麟麦酒株式会社 Rho標的タンパク質Rhoキナーゼ
AU9646198A (en) 1997-10-22 1999-05-10 Nippon Shinyaku Co. Ltd. Isoquinoline derivative and drug
WO1999061403A1 (en) 1998-05-25 1999-12-02 Santen Pharmaceutical Co., Ltd. Novel vinylbenzene derivatives
EP1020534B2 (en) 1998-11-09 2011-01-05 Eiken Kagaku Kabushiki Kaisha Process for synthesizing nucleic acid
AU2878200A (en) 1999-02-11 2000-08-29 Schepens Eye Research Institute, Inc., The Growth medium for human corneal endothelial cells
UY27224A1 (es) 2001-03-23 2002-10-31 Bayer Corp Inhibidores de la rho-quinasa
PE20020958A1 (es) 2001-03-23 2002-11-14 Bayer Corp Inhibidores de la rho-quinasa
US7109208B2 (en) 2001-04-11 2006-09-19 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents
WO2002100833A1 (en) 2001-06-12 2002-12-19 Sumitomo Pharmaceuticals Company, Limited Rho KINASE INHIBITORS
JP4505228B2 (ja) 2002-01-10 2010-07-21 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト Rho−キナーゼ阻害剤
US6690307B2 (en) 2002-01-22 2004-02-10 Nokia Corporation Adaptive variable length coding of digital video
MXPA04007196A (es) 2002-01-23 2005-06-08 Bayer Pharmaceuticals Corp Inhibidores de rho-quinasa.
EP1541559A4 (en) 2002-07-22 2007-08-22 Asahi Kasei Pharma Corp 5-SUBSTITUTED ISOQUINOLINE DERIVATIVE
CA2400996A1 (en) 2002-09-03 2004-03-03 Lisa Mckerracher 1,4-substituted cyclohexane derivatives
US7160894B2 (en) 2003-06-06 2007-01-09 Asahi Kasei Pharma Corporation Tricyclic compound
WO2005003101A2 (en) 2003-07-02 2005-01-13 Biofocus Discovery Limited Pyrazine and pyridine derivatives as rho kinase inhibitors
WO2005039564A1 (en) 2003-10-02 2005-05-06 Vertex Pharmaceuticals Incorporated Phthalimide compounds useful as protein kinase inhibitors
WO2005034866A2 (en) 2003-10-06 2005-04-21 Glaxo Group Limited Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors
ES2387780T3 (es) 2003-10-06 2012-10-01 Glaxosmithkline Llc Preparación de azabencimidazoles 1,6-disustituidos como inhibidores de quinasas
JP2007507547A (ja) 2003-10-06 2007-03-29 グラクソ グループ リミテッド キナーゼ阻害剤としての1,7−二置換アザベンゾイミダゾールの調製
JP2007015928A (ja) 2003-10-15 2007-01-25 Ube Ind Ltd 新規オレフィン誘導体
JP2007008816A (ja) 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
EP1679308B1 (en) 2003-10-15 2013-07-24 Ube Industries, Ltd. Novel indazole derivative
CA2556589A1 (en) 2004-02-24 2005-09-01 Bioaxone Therapeutique Inc. 4-substituted piperidine derivatives
AR049333A1 (es) 2004-04-02 2006-07-19 Vertex Pharma Azaindoles inhibidores de proteinquinasas rock y otras proteinas quinasas. composiciones farmaceuticas.
WO2006057270A1 (ja) 2004-11-26 2006-06-01 Asahi Kasei Pharma Corporation 含窒素3環化合物
CA2621181C (en) 2005-08-30 2011-04-19 Asahi Kasei Pharma Corporation 5-isoquinolinesulfonamide compounds
WO2009028631A1 (ja) * 2007-08-29 2009-03-05 Senju Pharmaceutical Co., Ltd. 角膜内皮細胞接着促進剤
EP2249800B1 (en) * 2008-02-04 2024-04-17 Jeffrey L. Goldberg Iron magnetic cells for localizing delivery and eye tissue repair
US8606848B2 (en) 2009-09-10 2013-12-10 Opentv, Inc. Method and system for sharing digital media content
WO2011080984A1 (en) * 2009-12-29 2011-07-07 Senju Pharmaceutical Co., Ltd. Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction
JP5835693B2 (ja) * 2010-02-05 2015-12-24 株式会社角膜再生研究所 角膜内皮細胞の培養方法、移植用角膜内皮細胞シートの製造方法および角膜内皮細胞培養キット
EP2547082B1 (en) 2010-03-08 2019-06-26 Nec Corporation Mobile communication terminal apparatus, method for controlling power consumption of mobile communication terminal apparatus, and recording medium
KR102124149B1 (ko) 2010-05-12 2020-06-18 인터디지탈 매디슨 페이튼트 홀딩스 통합된 유효성 맵 코딩을 위한 방법 및 장치
EP2765188B1 (en) * 2011-10-06 2017-12-06 Keio University Method for producing corneal endothelial cell
ES2897740T3 (es) * 2011-12-28 2022-03-02 Kyoto Prefectural Public Univ Corp Normalización del cultivo de células endoteliales de la córnea
US9616101B2 (en) * 2012-07-06 2017-04-11 Kyoto Prefectural Public University Corporation Differentiation marker and differentiation control of eye cell
US10017735B2 (en) 2012-07-18 2018-07-10 Singapore Health Services Pte Ltd Cell culture of corneal endothelial cells
US10174284B2 (en) * 2012-09-07 2019-01-08 Jcr Pharmaceuticals Co., Ltd. Medium, for culturing corneal endothelial cells, containing conditioned medium from mesenchymal stem cells
EP3029140A4 (en) 2013-07-30 2017-06-28 Kyoto Prefectural Public University Corporation Corneal endothelial cell marker
WO2015072580A1 (ja) * 2013-11-14 2015-05-21 学校法人同志社 細胞増殖促進または細胞障害抑制による角膜内皮治療薬
JP2016077450A (ja) 2014-10-15 2016-05-16 タツタ電線株式会社 医療用チューブ
EP3416658B1 (en) 2016-02-15 2023-03-22 Kyoto Prefectural Public University Corporation Human functional corneal endothelial cell and application thereof

Similar Documents

Publication Publication Date Title
JP2019510509A5 (https=)
Yin et al. Manufacturing of primed mesenchymal stromal cells for therapy
Cheng et al. The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities
CN102757936B (zh) 人脂肪干细胞增殖促进剂及其应用方法
Desroches et al. Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells
Barberini et al. Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential
Debnath et al. Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue
Baraniak et al. Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential
Nicoletti et al. Methods and procedures in adipose stem cells: state of the art and perspective for translation medicine
BR112014020119A2 (pt) cultura de células-tronco mesenquimais
He et al. Comparative study of mesenchymal stem cells from rat bone marrow and adipose tissue
Goligorsky Endothelial progenitor cells: from senescence to rejuvenation
CN102686724A (zh) 由人类多能干细胞产生间充质干细胞的方法以及通过所述方法产生的间充质干细胞
Deng et al. Endothelial differentiation of human Adipose‐derived stem cells on polyglycolic acid/polylactic acid mesh
TW201522638A (zh) 多能性幹細胞的製備方法、使用該製備方法而製備出多能性幹細胞、改善劑、以及該多能性幹細胞之分化誘導方法
Li et al. Direct intercellular communications dominate the interaction between adipose-derived MSCs and myofibroblasts against cardiac fibrosis
Zhou et al. c-Kit+ cells isolated from human fetal retinas represent a new population of retinal progenitor cells
JP2020530454A (ja) 安全な細胞治療薬を生成するためのプラットフォーム
JP2025000600A (ja) ヒト臍帯間葉系幹細胞シート及びその製造方法
US11492596B2 (en) Methods for differentiating cells into hepatic stellate cells
Ribeiro et al. Mechanical characterization of adult stem cells from bone marrow and perivascular niches
CN107075470A (zh) 哺乳动物肺球体和肺球体细胞及其应用
ITUB20159750A1 (it) Metodo per la promozione ed il miglioramento delle proprieta? del tessuto adiposo, tessuto e cellule ottenute tramite detto metodo
Lee et al. Improvement of cell cycle lifespan and genetic damage susceptibility of human mesenchymal stem cells by hypoxic priming
Tang et al. Assessment of cellular materials generated by co-cultured ‘inflamed’and healthy periodontal ligament stem cells from patient-matched groups